Results 221 to 230 of about 21,517,583 (302)

Increased Plasma Microbial tDR‐1 in At‐Risk Individuals Is Associated With Decreased Conversion to Clinical Rheumatoid Arthritis and Reduces an In Vitro Macrophage Type 1 Interferon Response

Arthritis &Rheumatology, EarlyView.
Objective Microbial small RNAs can regulate human genes. Higher plasma concentrations of microbial transfer RNA (tRNA)‐derived RNA‐1 (tDR‐1) were previously associated with lower rheumatoid arthritis (RA) disease activity. This study examined whether tDR‐1 concentrations differ in anticyclic citrullinated peptide‐3 positive (CCP3+) at‐risk individuals (
Anastasiia Phothisane, Tulsi K. Joishy, Carolina Ramirez‐Becerra, Qiong Wu, Jennifer Seifert, Marie L. Feser, Jill M. Norris, M. Kristen Demoruelle, LauraKay Moss, Kevin D. Deane, V. Michael Holers, Michelle J. Ormseth   +11 more
wiley   +1 more source

MAIT cell responses to S. aureus and sensitivity to HlgAB are modulated by activation and tissue-dependent virulence effects

Raineri EJM, Boulouis C, Mouchtaridi E, Nilsén V, Cai C, Kammann T, Tabusse J, Sekine T, Wild N, Constantz C, White E, Müller TR, Marchalot A, Ferreira S, Kaushal J, Mily A, Franklin M, Bonaiti E, Eichhorn M, Bassett J, Stamper C, Mak JYW, Fairlie DP, Tibbitt C, Norrby-Teglund A, Marquardt N, Mjösberg J, Jorns C, Driving J, Leeansyah E, Buggert M, Sandberg JK.   +31 more
europepmc   +1 more source

Relationships in anesthesia work areas between contamination measured as colony-forming units, <i>Staphylococcus aureus</i> detection<i>, and S. aureus</i> transmission. [PDF]

Anesthesiol Perioper Sci
Bhushan A, Dexter F, Brindeiro C, Loftus RW, Ituk U.   +4 more
europepmc   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Correction: Membrane-targeting antibacterial isoniazid schiff base against <i>S. aureus</i> and biofilms. [PDF]

Front Chem
Liu Y, Hu L, Liu B, Qu Z.
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular <i>S. aureus</i> Infections. [PDF]

ACS Appl Bio Mater
Nieto-Marín V, Fernandez-Soliz IA, Arboleda Valencia JW, Pletzer D, Buccini DF, Franco OL.   +5 more
europepmc   +1 more source

Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley   +1 more source

Surgical revision in the presence of an S. aureus infection increases virulence factor expression and activates a multi-tissue inflammatory response. [PDF]

NPJ Biofilms Microbiomes
Smith CJ, Moniodes AJ, Watkins AR, Melvage AG, Thompson TP, Choi E, Lucas AA, Gilmore BF, Schaer TP, Hickok NJ, Freeman TA.   +10 more
europepmc   +1 more source

Rapid onset and offset of the interaction between rifampicin and long‐acting cabotegravir/rilpivirine: A pharmacokinetic case report

British Journal of Clinical Pharmacology, EarlyView.
Long‐acting intramuscular cabotegravir/rilpivirine (LA CAB/RPV) is contraindicated with rifampicin because of the risk of markedly reduced antiretroviral exposure, although clinical pharmacokinetic data for this interaction are lacking. We describe a 49‐year‐old man with virologically suppressed HIV‐1 infection receiving LA CAB/RPV every 8 weeks who ...
Emilie M. Gieling, Lisanne A. H. Bevers, Wouter L. Smit, Rosa H. Elias, Annelies Verbon, David M. Burger, Berend J. van Welzen   +6 more
wiley   +1 more source